Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TGTXTGTX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TG Therapeutics, Inc.

GOLDMAN SACHS GROUP INC holds 2.3M shares of TGTX (TG Therapeutics, Inc.), worth $127.1M as of 2026-Q2. The position was increased (+1.2% shares). TGTX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$127.1M

Current Shares

2.3M

Total Value Change

+$79.8M

Total Shares Change

+739,922

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+1.2%
$127.1M0.0%$54.94
30
2026-Q1
Increased
2.3M
+11.5%
$76M0.0%$28.88
33
2025-Q4
Increased
2.1M
+35.0%
$61.1M0.0%$29.75
38
2025-Q3
Decreased
1.5M
-3.2%
$54.9M0.0%$36.83
0
2025-Q2
Decreased
1.6M
-18.2%
$56.5M0.0%$36.72
0
2025-Q1
Increased
1.9M
+21.9%
$75.7M0.0%$39.86
36
2024-Q4
New
1.6M
-
$47.4M0.0%$31.44
40

Other major holders of TGTX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used